Real-time enrollment status for this hypertrophic cardiomyopathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT05836259 |
| Recruiting Status | Recruiting |
| Condition | Hypertrophic Cardiomyopathy |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Tenaya Therapeutics |
| Last Updated on CT.gov | July 15, 2025 (Jul 15, 2025) |
As of March 2, 2026: Clinical trial NCT05836259 is currently recruiting participants. This clinical trial study for hypertrophic cardiomyopathy is actively seeking new participants at 10 locations across the United States. The study is sponsored by Tenaya Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05836259 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05836259 was last updated Jul 15, 2025 (July 15, 2025). HelloStudys verifies this status automatically.